Literature DB >> 26588186

Humanized Mouse Models for Transplant Immunology.

L L Kenney1, L D Shultz2, D L Greiner1, M A Brehm1.   

Abstract

Our understanding of the molecular pathways that control immune responses, particularly immunomodulatory molecules that control the extent and duration of an immune response, have led to new approaches in the field of transplantation immunology to induce allograft survival. These molecular pathways are being defined precisely in murine models and translated into clinical practice; however, many of the newly available drugs are human-specific reagents. Furthermore, many species-specific differences exist between mouse and human immune systems. Recent advances in the development of humanized mice, namely, immunodeficient mice engrafted with functional human immune systems, have led to the availability of a small animal model for the study of human immune responses. Humanized mice represent an important preclinical model system for evaluation of new drugs and identification of the mechanisms underlying human allograft rejection without putting patients at risk. This review highlights recent advances in the development of humanized mice and their use as preclinical models for the study of human allograft responses. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  animal models; basic (laboratory) research/science; cellular transplantation (non-islet); experimental; islet transplantation; regenerative medicine; rejection; stem cells; tolerance; translational research/science

Mesh:

Year:  2015        PMID: 26588186      PMCID: PMC5283075          DOI: 10.1111/ajt.13520

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  68 in total

1.  Immunogenicity of induced pluripotent stem cells.

Authors:  Tongbiao Zhao; Zhen-Ning Zhang; Zhili Rong; Yang Xu
Journal:  Nature       Date:  2011-05-13       Impact factor: 49.962

Review 2.  Humanized mice for immune system investigation: progress, promise and challenges.

Authors:  Leonard D Shultz; Michael A Brehm; J Victor Garcia-Martinez; Dale L Greiner
Journal:  Nat Rev Immunol       Date:  2012-10-12       Impact factor: 53.106

Review 3.  Overcoming current limitations in humanized mouse research.

Authors:  Michael A Brehm; Leonard D Shultz; Jeremy Luban; Dale L Greiner
Journal:  J Infect Dis       Date:  2013-11       Impact factor: 5.226

4.  Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse.

Authors:  Ikumi Katano; Takeshi Takahashi; Ryoji Ito; Tsutomu Kamisako; Takuma Mizusawa; Yuyo Ka; Tomoyuki Ogura; Hiroshi Suemizu; Yutaka Kawakami; Mamoru Ito
Journal:  J Immunol       Date:  2015-02-23       Impact factor: 5.422

Review 5.  Current advances in humanized mouse models.

Authors:  Ryoji Ito; Takeshi Takahashi; Ikumi Katano; Mamoru Ito
Journal:  Cell Mol Immunol       Date:  2012-02-13       Impact factor: 11.530

6.  Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse.

Authors:  A G Murray; P Petzelbauer; C C Hughes; J Costa; P Askenase; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

7.  Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries.

Authors:  Yinong Wang; William R Burns; Paul C Y Tang; Tai Yi; Jeffrey S Schechner; Hans-Guenter Zerwes; William C Sessa; Marc I Lorber; Jordan S Pober; George Tellides
Journal:  FASEB J       Date:  2004-01-20       Impact factor: 5.191

8.  Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells.

Authors:  Pervinder Sagoo; Niwa Ali; Garima Garg; Frank O Nestle; Robert I Lechler; Giovanna Lombardi
Journal:  Sci Transl Med       Date:  2011-05-18       Impact factor: 17.956

9.  An effective approach to prevent immune rejection of human ESC-derived allografts.

Authors:  Zhili Rong; Meiyan Wang; Zheng Hu; Martin Stradner; Shengyun Zhu; Huijuan Kong; Huanfa Yi; Ananda Goldrath; Yong-Guang Yang; Yang Xu; Xuemei Fu
Journal:  Cell Stem Cell       Date:  2014-01-02       Impact factor: 24.633

10.  Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.

Authors:  A L Putnam; N Safinia; A Medvec; M Laszkowska; M Wray; M A Mintz; E Trotta; G L Szot; W Liu; A Lares; K Lee; A Laing; R I Lechler; J L Riley; J A Bluestone; G Lombardi; Q Tang
Journal:  Am J Transplant       Date:  2013-09-18       Impact factor: 8.086

View more
  33 in total

Review 1.  Regulatory T cells in skin.

Authors:  Niwa Ali; Michael D Rosenblum
Journal:  Immunology       Date:  2017-08-04       Impact factor: 7.397

Review 2.  Understanding Normal and Malignant Human Hematopoiesis Using Next-Generation Humanized Mice.

Authors:  Yoriko Saito; Leonard D Shultz; Fumihiko Ishikawa
Journal:  Trends Immunol       Date:  2020-07-03       Impact factor: 16.687

3.  Multicellular Systems to Translate Somatic Cell Genome Editors to Humans.

Authors:  Victor Hernandez-Gordillo; Thomas Caleb Casolaro; Mo R Ebrahimkhani; Samira Kiani
Journal:  Curr Opin Biomed Eng       Date:  2020-10-10

Review 4.  Humanized mouse models of immunological diseases and precision medicine.

Authors:  Leonard D Shultz; James Keck; Lisa Burzenski; Sonal Jangalwe; Shantashri Vaidya; Dale L Greiner; Michael A Brehm
Journal:  Mamm Genome       Date:  2019-03-07       Impact factor: 2.957

Review 5.  Humanized mouse models of genetic immune disorders and hematological malignancies.

Authors:  Rajeev K Tyagi; Jing Li; Justin Jacobse; Scott B Snapper; Dror S Shouval; Jeremy A Goettel
Journal:  Biochem Pharmacol       Date:  2019-10-18       Impact factor: 5.858

6.  Research Techniques Made Simple: Mouse Bacterial Skin Infection Models for Immunity Research.

Authors:  Christine Youn; Nathan K Archer; Lloyd S Miller
Journal:  J Invest Dermatol       Date:  2020-05-11       Impact factor: 8.551

Review 7.  Targeting B Cells and Plasma Cells in Glomerular Diseases: Translational Perspectives.

Authors:  Eva Schrezenmeier; David Jayne; Thomas Dörner
Journal:  J Am Soc Nephrol       Date:  2018-01-11       Impact factor: 10.121

8.  Animal Models of Renal Pathophysiology and Disease.

Authors:  Adam Hosszu; Tamas Kaucsar; Erdmann Seeliger; Andrea Fekete
Journal:  Methods Mol Biol       Date:  2021

9.  Genetically modified human CD4(+) T cells can be evaluated in vivo without lethal graft-versus-host disease.

Authors:  Riyasat Ali; Jeffrey Babad; Antonia Follenzi; John A Gebe; Michael A Brehm; Gerald T Nepom; Leonard D Shultz; Dale L Greiner; Teresa P DiLorenzo
Journal:  Immunology       Date:  2016-08       Impact factor: 7.397

Review 10.  Humanized Mouse Models of Clinical Disease.

Authors:  Nicole C Walsh; Laurie L Kenney; Sonal Jangalwe; Ken-Edwin Aryee; Dale L Greiner; Michael A Brehm; Leonard D Shultz
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.